Navigation Links
Inverness Medical Innovations to Present at FBR Capital Markets 12th Annual Spring Investor Conference on May 28, 2008
Date:5/26/2008

WALTHAM, Mass., May 26 /PRNewswire-FirstCall/ -- Inverness Medical Innovations, Inc. (Amex: IMA), a leading manufacturer and marketer of rapid diagnostic products for the consumer and professional markets, announced today that it will attend the upcoming FBR Capital Markets 12th Annual Spring Investor Conference being held May 28, 2008 at the Grand Hyatt in New York. Ron Geraty, President, Health Management, and Jon Russell, Vice President, Finance, will attend. Their presentation is scheduled for Wednesday, May 28, 2008 at 9:45 a.m., and will be made available to the public through a webcast accessible through the company's website at http://www.invmed.com/investors.cfm and through FBR's website at http://www.wsw.com/webcast/fbr21/ima/ . A replay of the webcast will be available via the links above for 90 days. During their presentation Mr. Geraty or Mr. Russell may discuss and answer questions concerning business and financial developments and trends. Their responses to questions, as well as other matters discussed during the webcast, may contain or constitute information that has not been disclosed previously.

An investor presentation to be provided at the conference will be made available to the public on the company's website via the link provided above.

Inverness Medical Innovations is a leading global developer of advanced diagnostic devices and is presently exploring new opportunities for its proprietary electrochemical and other technologies in a variety of professional diagnostic and consumer-oriented applications including immuno- diagnostics with a focus on women's health, cardiology an
'/>"/>

SOURCE Inverness Medical Innovations, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Inverness Medical Innovations Completes Acquisition of Matria Healthcare, Inc.
2. Inverness Medical Innovations to Participate at Morgan Stanley Global Healthcare Unplugged Conference on April 30, 2008
3. Inverness Medical Innovations Announces First Quarter 2008 Results
4. Inverness Medical Innovations to Close Cholestech, HemoSense and BioStar Facilities
5. Inverness Medical Innovations to Participate at Bank of America 2008 Smid Cap Conference on March 26, 2008
6. Inverness Medical Innovations Announces Fourth Quarter 2007 Results
7. Inverness Medical Innovations Completes Acquisition of BBI Holdings Plc
8. Correction to Press Release Dated January 31, 2008: Inverness Medical Innovations to Participate at 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference on February 5, 2008
9. Inverness Medical Innovations to Participate at 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference on February 5, 2008
10. Inverness Medical Innovations to Participate at JP Morgan Healthcare Conference on January 8, 2008
11. Inverness Medical Innovations Acquires ParadigmHealth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... Halifax, Nova Scotia (PRWEB) February 27, 2015 ... has been made aware of a fraudulent press release ... GlobeNewswire, purporting to be from Immunovaccine. This press release ... with Gilead Science, Inc. The press release did ... to the information contained within the press release. ...
(Date:2/27/2015)... Mass. , Feb. 27, 2015 ... of the NCATS rare-diseases portfolio " in ... a new financing technique to reduce the risk ... diseases and potentially unlock new levels of funding ... The product of a unique collaboration between scientists ...
(Date:2/27/2015)... 27, 2015 The fully automated ... UC) can sequentially analyze up to 48 samples ... high-sensitivity detection of targets by mass spectrometry. ... fulfill the measurement requirements of a wide range ... drug delivery and search for disease biomarkers, additives ...
(Date:2/27/2015)... FamilyFarms Group is pleased to announce its valued ... received the 2015 Tomorrow’s Top Producer Horizon Award. The ... 35, who has demonstrated excellence in the business of ... Tomorrow's Top Producer Horizon Award. Every year I look ... and learning from their experiences. It is truly humbling ...
Breaking Biology Technology:Immunovaccine Disclaims Hoax Press Release 2New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 2New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 3New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 4Shimadzu Corporation Launches Nexera UC - The World’s Foremost Unified Chromatography System 2Shimadzu Corporation Launches Nexera UC - The World’s Foremost Unified Chromatography System 3Matt Sims Receives the 2015 Tomorrow’s Top Producer Horizon Award 2
... 25, 2011 Projects In Knowledge, a fully accredited ... digital and mobile information tools for busy clinicians, has ... The company,s website ( www.projectsinknowledge.com ) won an Award ... "Most Improved Web and Intranet Site." Launched in August ...
... Mich., July 25, 2011 Robert Ettinger, the founder of ... Saturday, July 23, at home in Clinton Township, Michigan, and ... storage at very low temperatures after death in the hope ... aging and disease. Mr. Ettinger wrote ...
... -   Text-to-speech application enables researchers to listen ...  Elsevier, a world leading provider of scientific, technical ... of an audio reader application from iSpeech, provider of cloud-based ... . The iSpeech Audio Reader is the latest in a ...
Cached Biology Technology:Two Health Industry Award Wins for Projects In Knowledge® 2Two Health Industry Award Wins for Projects In Knowledge® 3Founder of Cryonics Movement Dies, is Frozen at Cryonics Institute 2iSpeech® Develops Audio Reader for Elsevier's SciVerse Applications 2iSpeech® Develops Audio Reader for Elsevier's SciVerse Applications 3iSpeech® Develops Audio Reader for Elsevier's SciVerse Applications 4
(Date:2/5/2015)... Calif. , Jan. 30, 2015  It is ... great power and potential for genomic science as a ... in disease prevention and treatment.  I was honored to ... new, government-funded precision medicine program. Since ... the science of genomics—from the first sequenced genome of ...
(Date:1/22/2015)... , Jan. 22, 2015 Research and Markets ( ... - A Global Market Overview" report to their offering. ... is to ensure that an individual is who she/he is ... make use of a person,s unique physical characteristics, such as ...
(Date:1/22/2015)... /PRNewswire/ - Today, FindBiometrics, the leading source of biometrics industry news, ... website design. "When we launched FindBiometrics 12 years ... O,Neill , founder and CEO of FindBiometrics. "Now it,s maturing ... the key players on a very broad scale.  We are ...
Breaking Biology News(10 mins):J. Craig Venter, Ph.D., Co-Founder and CEO, Human Longevity, Inc. (HLI) Participates in White House Precision Medicine Event 2Biometrics - A Global Market Overview 2Biometrics - A Global Market Overview 3Identity Industry Leading Publication Debuts New Look As Biometrics Hit Mainstream 2
... in melanoma therapy. Patients whose melanoma lesions contain a ... a BRAF-specific inhibitor, PLX4032. Reports of the drug trial ... after therapy began the tumors returned and resumed growing. ... tumor learns to signal around the blocked gene by ...
... the southwestern United States are changing and will face ... declines during this century, according to a study conducted ... Service; University of California, Santa Barbara; U.S. Geological Survey; ... in the Proceedings of the National Academy of ...
... that the speed of early forest clearance following human ... much faster and more intense than previously thought. ... just a few large fires within 200 years of ... forest. Grasslands and shrubland replaced the burnt forest and ...
Cached Biology News:Killing drug-resistant melanoma requires combination therapy 2Killing drug-resistant melanoma requires combination therapy 3Drought and rising temperatures weaken southwest forests 2Early settlers rapidly transformed New Zealand forests with fire 2Early settlers rapidly transformed New Zealand forests with fire 3
Histone H2A Polyclonal Antibody 100 ug affinity purified rabbit polyclonal antibody. Detects ~14 kDa Histone H2A. It does not cross-react with other Histones. Reacts with human/mouse/rat. Performs w...
...
CMRL Medium-1066 (1X) liquid...
MMP-20 Immunogen: Activated recombinant human MMP-2 Storage: -20 C, Avoid Freeze/Thaw Cycles...
Biology Products: